Recent articles correlate AREG to tumour cell aggressiveness and chemoresistance 16, 17, 18, 21, 22, and it has been proposed a new extracrine (exosomal‐targeted receptor activation) signalling that involves the packaging and release of the EGFR ligand AREG via exosomes 20. Here, EGFR is linked to neoplasm.